These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of platelet factor 3 in the hypercoagulability induced by pregnancy and oral contraceptives. Renaud S; Gautheron P Thromb Diath Haemorrh; 1973 Nov; 30(2):299-306. PubMed ID: 4797961 [No Abstract] [Full Text] [Related]
4. [Adverse effects of ovulation inhibitors on blood coagulation, circulation and metabolism]. Ludwig H Internist (Berl); 1972 Jul; 13(7):286-92. PubMed ID: 4559269 [No Abstract] [Full Text] [Related]
5. Oral contraceptives and deep venous thrombosis with pulmonary embolism. Bouché RT; Medawar SJ; Dockery GL J Foot Surg; 1982; 21(4):297-301. PubMed ID: 7186920 [TBL] [Abstract][Full Text] [Related]
6. Blood clotting and the pill. Br Med J; 1972 Nov; 4(5837):378-9. PubMed ID: 4118011 [No Abstract] [Full Text] [Related]
7. Morphologic effects of oral contraceptives (Norinyle) on the guinea pig liver. Kim CS; Lee YB Yonsei Med J; 1980; 21(1):43-51. PubMed ID: 7269635 [No Abstract] [Full Text] [Related]
8. Oral contraceptives. Med Lett Drugs Ther; 1968 Aug; 10(17):66-8. PubMed ID: 5730144 [No Abstract] [Full Text] [Related]
9. Oral contraceptives and thromboembolic disease. I. Prospective and retrospective studies. Drill VA JAMA; 1972 Jan; 219(5):583-92. PubMed ID: 5066803 [No Abstract] [Full Text] [Related]
10. Oestrogen-progestogen oral contraception and blood clotting: a long-term follow-up. Poller L; Thomson JM; Thomas W Br Med J; 1971 Dec; 4(5788):648-50. PubMed ID: 5134560 [TBL] [Abstract][Full Text] [Related]
11. [Changes in the heparinocyte count during intake of hormonal contraceptives]. Frick G; Kühne D Zentralbl Gynakol; 1973 Oct; 95(41):1441-50. PubMed ID: 4129504 [No Abstract] [Full Text] [Related]
12. [Blood coagulation and fibrinolysis in patients treated with an anovulatory drug with estroprogestational action]. Schubert L; Gibelli A; De Nicola P Ann Ostet Ginecol Med Perinat; 1968 Jan; 90(1):48-58. PubMed ID: 5739142 [No Abstract] [Full Text] [Related]
13. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic]. de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370 [No Abstract] [Full Text] [Related]
14. [Contraception with two low-dosage mestranol-norethisterone combinations]. Tenhaeff D; Feldmann HU; Rupek R Fortschr Med; 1972 Apr; 90(12):479-82. PubMed ID: 4641330 [No Abstract] [Full Text] [Related]
15. [Increased thrombosis tendency due to ovulation inhibitors?]. Böhnel J; Stacher A Med Klin; 1965 Nov; 60(48):1951-5. PubMed ID: 5887998 [No Abstract] [Full Text] [Related]
16. The effect of oral contraceptives on factor VIII levels. Crowell EB; Clatanoff DV; Kiekhofer W J Lab Clin Med; 1971 Apr; 77(4):551-7. PubMed ID: 5554340 [No Abstract] [Full Text] [Related]
17. [Blood coagulation and oral ovulostatic steroids. (Case studies of 22 women treated for a long period, from 6 months to 3 years, with norethynodrel and mestranol)]. Conti M; Neglia V; Arrotta U Minerva Ginecol; 1967 Nov; 19(22):1091-4. PubMed ID: 5606233 [No Abstract] [Full Text] [Related]
18. Long-term evaluation of two oral contraceptives. Hutcherson WP; Schwartz HA; Weathers W; McGuire JE Fertil Steril; 1967; 18(5):616-31. PubMed ID: 6037450 [No Abstract] [Full Text] [Related]
19. [Blood coagulation during treatment with oral contraceptives]. Bailo U; Finzi C Minerva Ginecol; 1968 Dec; 20(23):1879-84. PubMed ID: 5734792 [No Abstract] [Full Text] [Related]